 | • レポートコード：QYR2104Z0023 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、尋常性痒疹治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（CB-0601、CJM-112、CLS-007、ダプソン、DFD-10、DLX-2323、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・尋常性痒疹治療の市場動向 ・企業の競争状況、市場シェア ・尋常性痒疹治療の種類別市場規模（CB-0601、CJM-112、CLS-007、ダプソン、DFD-10、DLX-2323、その他） ・尋常性痒疹治療の用途別市場規模（クリニック、病院、その他） ・尋常性痒疹治療の北米市場規模2016-2027（アメリカ、カナダ） ・尋常性痒疹治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・尋常性痒疹治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・尋常性痒疹治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・尋常性痒疹治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Common Pharma Inc、Cutanea Life Sciences Inc、Dermira Inc、ELORAC Inc、Ensol Biosciences Inc、Foamix Pharmaceuticals Ltd、Galderma SA、GlaxoSmithKline Plc、Helix BioMedix Inc、Hovione FarmaCiencia SA、Lee's Pharmaceutical Holdings Ltd、LEO Pharma A/S、Novabiotics Ltd、Novan Inc、Novartis AG、Paratek Pharmaceuticals Inc、Pfizer Inc、Phosphagenics Ltd） ・結論 |
Market Analysis and Insights: Global Acne Vulgaris Treatment Market
The global Acne Vulgaris Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acne Vulgaris Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acne Vulgaris Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acne Vulgaris Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acne Vulgaris Treatment market.
Global Acne Vulgaris Treatment Scope and Market Size
Acne Vulgaris Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acne Vulgaris Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
CB-0601
CJM-112
CLS-007
Dapsone
DFD-10
DLX-2323
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Common Pharma Inc
Cutanea Life Sciences Inc
Dermira Inc
ELORAC Inc
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline Plc
Helix BioMedix Inc
ELORAC Inc
Ensol Biosciences Inc
LEO Pharma A/S
Novabiotics Ltd
Novan Inc
Novartis AG
Paratek Pharmaceuticals Inc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acne Vulgaris Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CB-0601
1.2.3 CJM-112
1.2.4 CLS-007
1.2.5 Dapsone
1.2.6 DFD-10
1.2.7 DLX-2323
1.2.8 Others
1.3 Market by Application
1.3.1 Global Acne Vulgaris Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Acne Vulgaris Treatment Market Perspective (2016-2027)
2.2 Acne Vulgaris Treatment Growth Trends by Regions
2.2.1 Acne Vulgaris Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acne Vulgaris Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Acne Vulgaris Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Acne Vulgaris Treatment Industry Dynamic
2.3.1 Acne Vulgaris Treatment Market Trends
2.3.2 Acne Vulgaris Treatment Market Drivers
2.3.3 Acne Vulgaris Treatment Market Challenges
2.3.4 Acne Vulgaris Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acne Vulgaris Treatment Players by Revenue
3.1.1 Global Top Acne Vulgaris Treatment Players by Revenue (2016-2021)
3.1.2 Global Acne Vulgaris Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Acne Vulgaris Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acne Vulgaris Treatment Revenue
3.4 Global Acne Vulgaris Treatment Market Concentration Ratio
3.4.1 Global Acne Vulgaris Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acne Vulgaris Treatment Revenue in 2020
3.5 Acne Vulgaris Treatment Key Players Head office and Area Served
3.6 Key Players Acne Vulgaris Treatment Product Solution and Service
3.7 Date of Enter into Acne Vulgaris Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acne Vulgaris Treatment Breakdown Data by Type
4.1 Global Acne Vulgaris Treatment Historic Market Size by Type (2016-2021)
4.2 Global Acne Vulgaris Treatment Forecasted Market Size by Type (2022-2027)
5 Acne Vulgaris Treatment Breakdown Data by Application
5.1 Global Acne Vulgaris Treatment Historic Market Size by Application (2016-2021)
5.2 Global Acne Vulgaris Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Acne Vulgaris Treatment Market Size (2016-2027)
6.2 North America Acne Vulgaris Treatment Market Size by Type
6.2.1 North America Acne Vulgaris Treatment Market Size by Type (2016-2021)
6.2.2 North America Acne Vulgaris Treatment Market Size by Type (2022-2027)
6.2.3 North America Acne Vulgaris Treatment Market Size by Type (2016-2027)
6.3 North America Acne Vulgaris Treatment Market Size by Application
6.3.1 North America Acne Vulgaris Treatment Market Size by Application (2016-2021)
6.3.2 North America Acne Vulgaris Treatment Market Size by Application (2022-2027)
6.3.3 North America Acne Vulgaris Treatment Market Size by Application (2016-2027)
6.4 North America Acne Vulgaris Treatment Market Size by Country
6.4.1 North America Acne Vulgaris Treatment Market Size by Country (2016-2021)
6.4.2 North America Acne Vulgaris Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Acne Vulgaris Treatment Market Size (2016-2027)
7.2 Europe Acne Vulgaris Treatment Market Size by Type
7.2.1 Europe Acne Vulgaris Treatment Market Size by Type (2016-2021)
7.2.2 Europe Acne Vulgaris Treatment Market Size by Type (2022-2027)
7.2.3 Europe Acne Vulgaris Treatment Market Size by Type (2016-2027)
7.3 Europe Acne Vulgaris Treatment Market Size by Application
7.3.1 Europe Acne Vulgaris Treatment Market Size by Application (2016-2021)
7.3.2 Europe Acne Vulgaris Treatment Market Size by Application (2022-2027)
7.3.3 Europe Acne Vulgaris Treatment Market Size by Application (2016-2027)
7.4 Europe Acne Vulgaris Treatment Market Size by Country
7.4.1 Europe Acne Vulgaris Treatment Market Size by Country (2016-2021)
7.4.2 Europe Acne Vulgaris Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Acne Vulgaris Treatment Market Size (2016-2027)
8.2 Asia-Pacific Acne Vulgaris Treatment Market Size by Type
8.2.1 Asia-Pacific Acne Vulgaris Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acne Vulgaris Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acne Vulgaris Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Acne Vulgaris Treatment Market Size by Application
8.3.1 Asia-Pacific Acne Vulgaris Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acne Vulgaris Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acne Vulgaris Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Acne Vulgaris Treatment Market Size by Region
8.4.1 Asia-Pacific Acne Vulgaris Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acne Vulgaris Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Acne Vulgaris Treatment Market Size (2016-2027)
9.2 Latin America Acne Vulgaris Treatment Market Size by Type
9.2.1 Latin America Acne Vulgaris Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Acne Vulgaris Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Acne Vulgaris Treatment Market Size by Type (2016-2027)
9.3 Latin America Acne Vulgaris Treatment Market Size by Application
9.3.1 Latin America Acne Vulgaris Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Acne Vulgaris Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Acne Vulgaris Treatment Market Size by Application (2016-2027)
9.4 Latin America Acne Vulgaris Treatment Market Size by Country
9.4.1 Latin America Acne Vulgaris Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Acne Vulgaris Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acne Vulgaris Treatment Market Size (2016-2027)
10.2 Middle East & Africa Acne Vulgaris Treatment Market Size by Type
10.2.1 Middle East & Africa Acne Vulgaris Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acne Vulgaris Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acne Vulgaris Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Acne Vulgaris Treatment Market Size by Application
10.3.1 Middle East & Africa Acne Vulgaris Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acne Vulgaris Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acne Vulgaris Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Acne Vulgaris Treatment Market Size by Country
10.4.1 Middle East & Africa Acne Vulgaris Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acne Vulgaris Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Common Pharma Inc
11.1.1 Common Pharma Inc Company Details
11.1.2 Common Pharma Inc Business Overview
11.1.3 Common Pharma Inc Acne Vulgaris Treatment Introduction
11.1.4 Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.1.5 Common Pharma Inc Recent Development
11.2 Cutanea Life Sciences Inc
11.2.1 Cutanea Life Sciences Inc Company Details
11.2.2 Cutanea Life Sciences Inc Business Overview
11.2.3 Cutanea Life Sciences Inc Acne Vulgaris Treatment Introduction
11.2.4 Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.2.5 Cutanea Life Sciences Inc Recent Development
11.3 Dermira Inc
11.3.1 Dermira Inc Company Details
11.3.2 Dermira Inc Business Overview
11.3.3 Dermira Inc Acne Vulgaris Treatment Introduction
11.3.4 Dermira Inc Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.3.5 Dermira Inc Recent Development
11.4 ELORAC Inc
11.4.1 ELORAC Inc Company Details
11.4.2 ELORAC Inc Business Overview
11.4.3 ELORAC Inc Acne Vulgaris Treatment Introduction
11.4.4 ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.4.5 ELORAC Inc Recent Development
11.5 Ensol Biosciences Inc
11.5.1 Ensol Biosciences Inc Company Details
11.5.2 Ensol Biosciences Inc Business Overview
11.5.3 Ensol Biosciences Inc Acne Vulgaris Treatment Introduction
11.5.4 Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.5.5 Ensol Biosciences Inc Recent Development
11.6 Foamix Pharmaceuticals Ltd
11.6.1 Foamix Pharmaceuticals Ltd Company Details
11.6.2 Foamix Pharmaceuticals Ltd Business Overview
11.6.3 Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Introduction
11.6.4 Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.6.5 Foamix Pharmaceuticals Ltd Recent Development
11.7 Galderma SA
11.7.1 Galderma SA Company Details
11.7.2 Galderma SA Business Overview
11.7.3 Galderma SA Acne Vulgaris Treatment Introduction
11.7.4 Galderma SA Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.7.5 Galderma SA Recent Development
11.8 GlaxoSmithKline Plc
11.8.1 GlaxoSmithKline Plc Company Details
11.8.2 GlaxoSmithKline Plc Business Overview
11.8.3 GlaxoSmithKline Plc Acne Vulgaris Treatment Introduction
11.8.4 GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.8.5 GlaxoSmithKline Plc Recent Development
11.9 Helix BioMedix Inc
11.9.1 Helix BioMedix Inc Company Details
11.9.2 Helix BioMedix Inc Business Overview
11.9.3 Helix BioMedix Inc Acne Vulgaris Treatment Introduction
11.9.4 Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.9.5 Helix BioMedix Inc Recent Development
11.10 Hovione FarmaCiencia SA
11.10.1 Hovione FarmaCiencia SA Company Details
11.10.2 Hovione FarmaCiencia SA Business Overview
11.10.3 Hovione FarmaCiencia SA Acne Vulgaris Treatment Introduction
11.10.4 Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.10.5 Hovione FarmaCiencia SA Recent Development
11.11 Lee’s Pharmaceutical Holdings Ltd
11.11.1 Lee’s Pharmaceutical Holdings Ltd Company Details
11.11.2 Lee’s Pharmaceutical Holdings Ltd Business Overview
11.11.3 Lee’s Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Introduction
11.11.4 Lee’s Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.11.5 Lee’s Pharmaceutical Holdings Ltd Recent Development
11.12 LEO Pharma A/S
11.12.1 LEO Pharma A/S Company Details
11.12.2 LEO Pharma A/S Business Overview
11.12.3 LEO Pharma A/S Acne Vulgaris Treatment Introduction
11.12.4 LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.12.5 LEO Pharma A/S Recent Development
11.13 Novabiotics Ltd
11.13.1 Novabiotics Ltd Company Details
11.13.2 Novabiotics Ltd Business Overview
11.13.3 Novabiotics Ltd Acne Vulgaris Treatment Introduction
11.13.4 Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.13.5 Novabiotics Ltd Recent Development
11.14 Novan Inc
11.14.1 Novan Inc Company Details
11.14.2 Novan Inc Business Overview
11.14.3 Novan Inc Acne Vulgaris Treatment Introduction
11.14.4 Novan Inc Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.14.5 Novan Inc Recent Development
11.15 Novartis AG
11.15.1 Novartis AG Company Details
11.15.2 Novartis AG Business Overview
11.15.3 Novartis AG Acne Vulgaris Treatment Introduction
11.15.4 Novartis AG Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.15.5 Novartis AG Recent Development
11.16 Paratek Pharmaceuticals Inc
11.16.1 Paratek Pharmaceuticals Inc Company Details
11.16.2 Paratek Pharmaceuticals Inc Business Overview
11.16.3 Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Introduction
11.16.4 Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.16.5 Paratek Pharmaceuticals Inc Recent Development
11.17 Pfizer Inc
11.17.1 Pfizer Inc Company Details
11.17.2 Pfizer Inc Business Overview
11.17.3 Pfizer Inc Acne Vulgaris Treatment Introduction
11.17.4 Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.17.5 Pfizer Inc Recent Development
11.18 Phosphagenics Ltd
11.18.1 Phosphagenics Ltd Company Details
11.18.2 Phosphagenics Ltd Business Overview
11.18.3 Phosphagenics Ltd Acne Vulgaris Treatment Introduction
11.18.4 Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2016-2021)
11.18.5 Phosphagenics Ltd Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Acne Vulgaris Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CB-0601
Table 3. Key Players of CJM-112
Table 4. Key Players of CLS-007
Table 5. Key Players of Dapsone
Table 6. Key Players of DFD-10
Table 7. Key Players of DLX-2323
Table 8. Key Players of Others
Table 9. Global Acne Vulgaris Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Acne Vulgaris Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Acne Vulgaris Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Acne Vulgaris Treatment Market Share by Regions (2016-2021)
Table 13. Global Acne Vulgaris Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Acne Vulgaris Treatment Market Share by Regions (2022-2027)
Table 15. Acne Vulgaris Treatment Market Trends
Table 16. Acne Vulgaris Treatment Market Drivers
Table 17. Acne Vulgaris Treatment Market Challenges
Table 18. Acne Vulgaris Treatment Market Restraints
Table 19. Global Acne Vulgaris Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Acne Vulgaris Treatment Market Share by Players (2016-2021)
Table 21. Global Top Acne Vulgaris Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acne Vulgaris Treatment as of 2020)
Table 22. Ranking of Global Top Acne Vulgaris Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Acne Vulgaris Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Acne Vulgaris Treatment Product Solution and Service
Table 26. Date of Enter into Acne Vulgaris Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Acne Vulgaris Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Acne Vulgaris Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Acne Vulgaris Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Acne Vulgaris Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Acne Vulgaris Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Acne Vulgaris Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Acne Vulgaris Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Acne Vulgaris Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Acne Vulgaris Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Acne Vulgaris Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Acne Vulgaris Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Acne Vulgaris Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Acne Vulgaris Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Acne Vulgaris Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Acne Vulgaris Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Acne Vulgaris Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Acne Vulgaris Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Acne Vulgaris Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Acne Vulgaris Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Acne Vulgaris Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acne Vulgaris Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Acne Vulgaris Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Acne Vulgaris Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Acne Vulgaris Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Acne Vulgaris Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Acne Vulgaris Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Acne Vulgaris Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Acne Vulgaris Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Acne Vulgaris Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Acne Vulgaris Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Acne Vulgaris Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Acne Vulgaris Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acne Vulgaris Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Acne Vulgaris Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Acne Vulgaris Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Acne Vulgaris Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Acne Vulgaris Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Acne Vulgaris Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. Common Pharma Inc Company Details
Table 67. Common Pharma Inc Business Overview
Table 68. Common Pharma Inc Acne Vulgaris Treatment Product
Table 69. Common Pharma Inc Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 70. Common Pharma Inc Recent Development
Table 71. Cutanea Life Sciences Inc Company Details
Table 72. Cutanea Life Sciences Inc Business Overview
Table 73. Cutanea Life Sciences Inc Acne Vulgaris Treatment Product
Table 74. Cutanea Life Sciences Inc Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 75. Cutanea Life Sciences Inc Recent Development
Table 76. Dermira Inc Company Details
Table 77. Dermira Inc Business Overview
Table 78. Dermira Inc Acne Vulgaris Treatment Product
Table 79. Dermira Inc Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 80. Dermira Inc Recent Development
Table 81. ELORAC Inc Company Details
Table 82. ELORAC Inc Business Overview
Table 83. ELORAC Inc Acne Vulgaris Treatment Product
Table 84. ELORAC Inc Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 85. ELORAC Inc Recent Development
Table 86. Ensol Biosciences Inc Company Details
Table 87. Ensol Biosciences Inc Business Overview
Table 88. Ensol Biosciences Inc Acne Vulgaris Treatment Product
Table 89. Ensol Biosciences Inc Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 90. Ensol Biosciences Inc Recent Development
Table 91. Foamix Pharmaceuticals Ltd Company Details
Table 92. Foamix Pharmaceuticals Ltd Business Overview
Table 93. Foamix Pharmaceuticals Ltd Acne Vulgaris Treatment Product
Table 94. Foamix Pharmaceuticals Ltd Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 95. Foamix Pharmaceuticals Ltd Recent Development
Table 96. Galderma SA Company Details
Table 97. Galderma SA Business Overview
Table 98. Galderma SA Acne Vulgaris Treatment Product
Table 99. Galderma SA Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 100. Galderma SA Recent Development
Table 101. GlaxoSmithKline Plc Company Details
Table 102. GlaxoSmithKline Plc Business Overview
Table 103. GlaxoSmithKline Plc Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 104. GlaxoSmithKline Plc Recent Development
Table 105. Helix BioMedix Inc Company Details
Table 106. Helix BioMedix Inc Business Overview
Table 107. Helix BioMedix Inc Acne Vulgaris Treatment Product
Table 108. Helix BioMedix Inc Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 109. Helix BioMedix Inc Recent Development
Table 110. Hovione FarmaCiencia SA Company Details
Table 111. Hovione FarmaCiencia SA Business Overview
Table 112. Hovione FarmaCiencia SA Acne Vulgaris Treatment Product
Table 113. Hovione FarmaCiencia SA Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 114. Hovione FarmaCiencia SA Recent Development
Table 115. Lee's Pharmaceutical Holdings Ltd Company Details
Table 116. Lee's Pharmaceutical Holdings Ltd Business Overview
Table 117. Lee's Pharmaceutical Holdings Ltd Acne Vulgaris Treatment Product
Table 118. Lee's Pharmaceutical Holdings Ltd Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 119. Lee's Pharmaceutical Holdings Ltd Recent Development
Table 120. LEO Pharma A/S Company Details
Table 121. LEO Pharma A/S Business Overview
Table 122. LEO Pharma A/S Acne Vulgaris Treatment Product
Table 123. LEO Pharma A/S Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 124. LEO Pharma A/S Recent Development
Table 125. Novabiotics Ltd Company Details
Table 126. Novabiotics Ltd Business Overview
Table 127. Novabiotics Ltd Acne Vulgaris Treatment Product
Table 128. Novabiotics Ltd Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 129. Novabiotics Ltd Recent Development
Table 130. Novan Inc Company Details
Table 131. Novan Inc Business Overview
Table 132. Novan Inc Acne Vulgaris Treatment Product
Table 133. Novan Inc Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 134. Novan Inc Recent Development
Table 135. Novartis AG Company Details
Table 136. Novartis AG Business Overview
Table 137. Novartis AG Acne Vulgaris Treatment Product
Table 138. Novartis AG Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 139. Novartis AG Recent Development
Table 140. Paratek Pharmaceuticals Inc Company Details
Table 141. Paratek Pharmaceuticals Inc Business Overview
Table 142. Paratek Pharmaceuticals Inc Acne Vulgaris Treatment Product
Table 143. Paratek Pharmaceuticals Inc Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 144. Paratek Pharmaceuticals Inc Recent Development
Table 145. Pfizer Inc Company Details
Table 146. Pfizer Inc Business Overview
Table 147. Pfizer Inc Acne Vulgaris Treatment Product
Table 148. Pfizer Inc Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 149. Pfizer Inc Recent Development
Table 150. Phosphagenics Ltd Company Details
Table 151. Phosphagenics Ltd Business Overview
Table 152. Phosphagenics Ltd Acne Vulgaris Treatment Product
Table 153. Phosphagenics Ltd Revenue in Acne Vulgaris Treatment Business (2016-2021) & (US$ Million)
Table 154. Phosphagenics Ltd Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acne Vulgaris Treatment Market Share by Type: 2020 VS 2027
Figure 2. CB-0601 Features
Figure 3. CJM-112 Features
Figure 4. CLS-007 Features
Figure 5. Dapsone Features
Figure 6. DFD-10 Features
Figure 7. DLX-2323 Features
Figure 8. Others Features
Figure 9. Global Acne Vulgaris Treatment Market Share by Application: 2020 VS 2027
Figure 10. Clinic Case Studies
Figure 11. Hospital Case Studies
Figure 12. Others Case Studies
Figure 13. Acne Vulgaris Treatment Report Years Considered
Figure 14. Global Acne Vulgaris Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Acne Vulgaris Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Acne Vulgaris Treatment Market Share by Regions: 2020 VS 2027
Figure 17. Global Acne Vulgaris Treatment Market Share by Regions (2022-2027)
Figure 18. Global Acne Vulgaris Treatment Market Share by Players in 2020
Figure 19. Global Top Acne Vulgaris Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acne Vulgaris Treatment as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Acne Vulgaris Treatment Revenue in 2020
Figure 21. Global Acne Vulgaris Treatment Revenue Market Share by Type (2016-2021)
Figure 22. Global Acne Vulgaris Treatment Revenue Market Share by Type (2022-2027)
Figure 23. North America Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Acne Vulgaris Treatment Market Share by Type (2016-2027)
Figure 25. North America Acne Vulgaris Treatment Market Share by Application (2016-2027)
Figure 26. North America Acne Vulgaris Treatment Market Share by Country (2016-2027)
Figure 27. United States Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Acne Vulgaris Treatment Market Share by Type (2016-2027)
Figure 31. Europe Acne Vulgaris Treatment Market Share by Application (2016-2027)
Figure 32. Europe Acne Vulgaris Treatment Market Share by Country (2016-2027)
Figure 33. Germany Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Acne Vulgaris Treatment Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Acne Vulgaris Treatment Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Acne Vulgaris Treatment Market Share by Region (2016-2027)
Figure 43. China Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Acne Vulgaris Treatment Market Share by Type (2016-2027)
Figure 51. Latin America Acne Vulgaris Treatment Market Share by Application (2016-2027)
Figure 52. Latin America Acne Vulgaris Treatment Market Share by Country (2016-2027)
Figure 53. Mexico Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Acne Vulgaris Treatment Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Acne Vulgaris Treatment Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Acne Vulgaris Treatment Market Share by Country (2016-2027)
Figure 59. Turkey Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Acne Vulgaris Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Common Pharma Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 63. Cutanea Life Sciences Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 64. Dermira Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 65. ELORAC Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 66. Ensol Biosciences Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 67. Foamix Pharmaceuticals Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 68. Galderma SA Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 69. GlaxoSmithKline Plc Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 70. Helix BioMedix Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 71. Hovione FarmaCiencia SA Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 72. Lee's Pharmaceutical Holdings Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 73. LEO Pharma A/S Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 74. Novabiotics Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 75. Novan Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 76. Novartis AG Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 77. Paratek Pharmaceuticals Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 78. Pfizer Inc Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 79. Phosphagenics Ltd Revenue Growth Rate in Acne Vulgaris Treatment Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界の尋常性痒疹市場規模・現状・予測（2021年-2027年） Acne, also known as acne vulgaris, is a long-term skin disease that occurs when hair follicles are clogged with dead skin cells and oil from the skin. Acne Vulgaris is seen to occur mostly in adolescence. At puberty androgens due to the increase in sebum production from enlarged sebaceous glands, th…- 世界の尋常性痒疹市場規模・現状・予測（2021年-2027年） Acne, also known as acne vulgaris, is a long-term skin disease that occurs when hair follicles are clogged with dead skin cells and oil from the skin. Acne Vulgaris is seen to occur mostly in adolescence. At puberty androgens due to the increase in sebum production from enlarged sebaceous glands, th…
- 世界のニキビ治療市場規模・現状・予測（2021年-2027年） Acne is considered to be among the topmost prevalent diseases in the world. The inflammatory acne segment is the largest acne type segment in the global acne treatment market. The average age of onset of acne has reduced from 14-15 years to 11-12 years due to changing demographics and social habits.…
- 世界のニキビ治療薬市場規模・現状・予測（2021年-2027年） Acne, also known as acne vulgaris, is a long-term skin condition that occurs when dead skin cells and oil from the skin clog hair follicles. Typical features of the condition include blackheads or whiteheads, pimples, oily skin, and possible scarring. It primarily affects skin with a relatively high…
- 世界のニキビ市場規模・現状・予測（2021年-2027年） Acne is defined as a chronic skin disorder in which the hair follicles become blocked and/or inflamed. There are several variants of acne and they range from mild to severe. The most common type of acne is acne vulgaris (vulgaris means common). Acne appears most often on the facebut can also be a nu…